MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Bio-Rad Laboratories Company Profile (NYSE:BIO)

Consensus Ratings for Bio-Rad Laboratories (NYSE:BIO) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $174.50 (25.38% upside)

Analysts' Ratings History for Bio-Rad Laboratories (NYSE:BIO)
Show:
DateFirmActionRatingPrice TargetActions
6/8/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Leerink SwannBoost Price Target$143.00 -> $149.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Bio-Rad Laboratories (NYSE:BIO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/5/2016Q1$0.60$0.42$463.90 million$471.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q415$1.27$1.68$570.80 million$570.56 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315$0.54$0.59$495.55 million$469.96 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215$0.78$0.97$494.85 million$506.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115$0.33$0.61$474.60 million$472.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q414$1.18$1.34$593.41 million$598.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314$0.86$0.39$525.40 million$530.64 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214$0.95$1.09$537.58 million$536.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q114$0.80$0.23$515.00 million$509.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/27/2014Q413$1.42$1.04$586.67 million$602.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313$0.91($0.25)$529.02 million$505.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013$1.25$1.20$532.60 million$525.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2013Q1 2013$1.03$0.68$506.34 million$499.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2013Q4 2012$1.33$1.65$558.68 million$573.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2012Q312$1.14$1.48$507.79 million$498.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2012$1.19$1.69ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2012$1.02$1.09ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2012$1.67$2.08ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$1.53$1.61ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2011$1.47$1.41ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011$1.32$1.16ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/24/2011$1.35$2.41ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Bio-Rad Laboratories (NYSE:BIO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.72$0.85$0.79
Q2 20163$1.01$1.12$1.07
Q3 20162$0.84$0.92$0.88
Q4 20163$1.09$1.55$1.25
(Data provided by Zacks Investment Research)
Dividend History for Bio-Rad Laboratories (NYSE:BIO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Bio-Rad Laboratories (NYSE:BIO)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Bio-Rad Laboratories (NYSE:BIO)
DateHeadline
06/29/16 07:57 PMSexually Transmitted Diseases (STDs) Testing Market 2016: Global Industry Size, Shares, Growth, Analysis, and Forecasts to 2021
06/29/16 11:07 AMBio-Rad Laboratories, Inc. (NYSE:BIO) Current Analyst Ratings - Fiscal Standard
06/28/16 03:01 PMReport explores the global sexually transmitted diseases testing market 2016: industry size, share, growth and analysis 2020
06/28/16 03:01 PMHemoglobin A1c Monitoring Market 2015-2022 - Global Strategic Business Report 2016 - Research and Markets
06/28/16 03:01 PMAsia-Pacific In-Vitro Diagnostics Market is Expected to Reach $19.0 Billion by 2022
06/28/16 07:18 AMTop Stock Pick for Quarter: Bio-Rad Laboratories, Inc. (NYSE:BIO) - Engelwood Daily
06/27/16 02:29 PMBio-Rad Laboratories Breaks Below 200-Day Moving Average - Notable for BIO - Nasdaq
06/27/16 07:31 AMResearch report explores the DNA diagnostics market 2016: global industry size, demand, segement and growth to 2020
06/27/16 07:31 AMExosome Diagnostics Appoints Mario Morken as Director of Business Development
06/26/16 08:03 AMStock Performance Focus on: Bio-Rad Laboratories, Inc. (NYSE:BIO) - Press Telegraph
06/25/16 02:48 PMStrong Sell Calls Recommendations For Bio-Rad Laboratories, Inc. (NYSE:BIO) At 0 - Investor Newswire
06/24/16 07:59 PMBio-Rad Laboratories, Inc. Stock Is Crashing Now. What To Expect? - Engelwood Daily
06/24/16 02:51 PMNew Market Research Report: In Vitro Toxicology Testing Market - Global Forecast to 2021
06/24/16 02:51 PMGlobal Diagnostic Testing of Sexually Transmitted Diseases (STDs) is estimated to rise at a Strong CAGR Of 8.5% Forecast Period 2014-2020
06/24/16 06:34 AMBio-Rad Laboratories, Inc. (NYSE:BIO) Yearly Sales Target At $2087.9 - Investor Newswire
06/23/16 04:23 PMGlobal cell lysis industry consumption forecast to 2021 scrutinized in new research
06/23/16 04:23 PMGlobal Hemoglobin A1c Monitoring Industry
06/23/16 10:41 AMSample Preparation Market Growth Steady at 5.5% CAGR to 2021
06/23/16 10:41 AMAutoimmune Disease Diagnostics Market to Achieve USD 14.8 Billion by 2020 on Account of High Prevalence
06/22/16 07:36 AMDiscover the global DNA diagnostics market 2016: industry size, shares growth, analysis and forecast to 2020
06/22/16 07:36 AMIn Vitro Toxicology Testing Market by Product, Type, Toxicity Endpoints & Tests, Technology, Method, Industry - Global Forecast to 2021
06/22/16 07:36 AMBio Rad Laboratories : Assigned Patent
06/21/16 07:36 AMSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Bio-Rad Laboratories, Inc. for Potential ... - PR Newswire (press release)
06/20/16 02:51 PMElectrophoresis 2016 World Market Research,Adoption and Industrial Overview Report Forecasting to 2022
06/20/16 02:51 PMSample preparation market poised to be 7,203.2 million USD by 2021
06/20/16 02:51 PMBio-Rad’s New Software Makes Purifying Proteins with NGC™ Chromatography Systems Even Easier
06/20/16 01:06 PMETF’s with exposure to Bio-Rad Laboratories, Inc. : June 20, 2016 -
06/20/16 09:15 AMImmunoassay 2016 World Market Leaders,Future Demand,Company Profiles and Industrial Overview Research Report Forecasting to 2022
06/20/16 09:15 AMLearn details of the adme toxicology testing market research and analysis report 2015 to 2022
06/20/16 09:15 AMImmunoassay 2016 World Market Research,Adoption and Industrial Overview Report Forecasting to 2022
06/19/16 02:44 PMThis Weeks Broker Views For Bio-Rad Laboratories, Inc. (NYSE:BIO) - Fiscal Standard
06/19/16 07:31 AMStrong Buy Calls Count For Bio-Rad Laboratories, Inc. (NYSE:BIO) At 1 - Investor Newswire
06/17/16 02:46 PMIQ4I Research & Consultancy Published a New Report on “PCR Technologies Global Market – Forecast To 2022”
06/17/16 02:46 PMGlobal polymerase chain reaction industry consumption forecast to 2021 published by leading research firm
06/17/16 10:54 AMBio-Rad Laboratories, Inc. – Value Analysis (NYSE:BIO) : June 17, 2016 -
06/16/16 02:50 PMGlycated Haemoglobin Testing Market : Size, Application Analysis, Regional Outlook to 2014 – 2020
06/16/16 02:50 PMOversold Conditions For Bio-Rad Laboratories (BIO)
06/16/16 07:12 AMBio-Rad Laboratories, Inc. breached its 50 day moving average in a Bearish Manner : BIO-US : June 16, 2016 -
06/15/16 07:39 AMLabel-Free Detection Systems Market : Latest Innovations, Drivers, Restraints, Challenges and Key Events in the industry by 2014 – 2020
06/14/16 02:48 PMSample Preparation Market Worth 7,203.2 Million USD by 2021
06/14/16 07:58 AMCardiac Biomarkers Market Share,Supply and Consumption 2016 Market Research Report and Forecast to 2021
06/13/16 03:04 PMIn Vitro Toxicology Testing Market to Grow at 14.1% CAGR to 2021 Led by Systemic Toxicity
06/13/16 10:51 AMMicrofluidics Market to Grow at CAGR 16% 2016 and Forecast to 2020
06/13/16 10:51 AMMicrofluidics market share,supply and consumption 2016 market research and forecast to 2021 illuminated by new report
06/09/16 02:50 PMBio-Rad Laboratories, Inc. (NYSE:BIO) Fundamental Star Rating Report - CML News
06/07/16 08:28 PMBio-Rad Announces the Release of Liquichek™ Maternal Serum II Control - SelectScience.net (press release) (registration)
06/06/16 02:43 PMRand Logistics, Inc. (NASDAQ:RLOG) Surged 10.00%: Pfizer Inc. (NYSE:PFE), Bio-Rad Laboratories, Inc. (NYSE:BIO ... - KC Register
06/06/16 02:43 PMBio-Rad Laboratories, Inc. (NYSE:BIO) Earns Rating Score Of 2 - RealistInvestor.com
06/05/16 08:08 PMIn Vitro Toxicology Testing Market Worth 27.36 Billion USD by 2021
06/05/16 08:08 PMFood & Beverage Market Research News
About Bio-Rad Laboratories

Bio-Rad Laboratories logoBio-Rad Laboratories, Inc. (Bio-Rad) manufactures and supplies products and systems used for the life science research, healthcare, analytical chemistry and other markets. The Company offers products to separate complex chemical and biological materials, and to identify, analyze and purify their components. Bio-Rad operates in two segments: Life Science and Clinical Diagnostics. The Company's Life Science segment develops, manufactures and markets a range of over 5,000 reagents, apparatus and laboratory instruments. The Company's Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and quality controls that serve clinical laboratories in the global diagnostics market. Bio-Rad's product brands include Droplet Digital and BioPlex. As of December 31, 2014, the Company had direct distribution channels in over 35 countries outside the United States through subsidiaries.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NYSE
  • Symbol: BIO
  • CUSIP: 09057220
Key Metrics:
  • Previous Close: $139.18
  • 50 Day Moving Average: $144.41
  • 200 Day Moving Average: $137.13
  • P/E Ratio: 38.06
  • P/E Growth: 4.30
  • Market Cap: $4.09B
  • Current Quarter EPS Consensus Estimate: $3.31 EPS
Additional Links:
Bio-Rad Laboratories (NYSE:BIO) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha